National Stockpiles Affect Medicine Access in Some EU Countries
Medicines for Europe shared on LinkedIn:
”Fragmented national stockpiling policies are making essential medicines harder to access in some EU countries, extending shortages and exposing our internal market.
In Germany, a 6-month stockpile equals almost 2 years’ supply for the Netherlands. Uncoordinated stockpiling risks destabilizing smaller markets and reducing treatment availability in other regions.
For example, 70% of companies have observed longer stockout periods and reduced availability of medicines in smaller markets, due to stockpiling requirements.
We need a unified approach to ensure timely and equal access for patients, as well as robust supply chains based on proportionate measures and EU solidarity.
Check out our report to learn more.”
Find more posts on Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?